139 results
Page 2 of 7
8-K
EX-99.1
op2x 9aqxjk
12 May 23
Adaptimmune Reports First Quarter Financial Results and Business Update
7:36am
424B3
3lwy95xgdy eq0x
20 Apr 23
Prospectus supplement
4:32pm
S-4/A
8ovmp
18 Apr 23
Registration of securities issued in business combination transactions (amended)
4:01pm
8-K
EX-10.1
5msnomvsl8lhn
11 Apr 23
Adaptimmune and GSK Have Agreed Terms for Transfer of PRAME and NY-ESO Target Programs back to Adaptimmune
8:08am
S-4
l8zzl3wo44qwodm7o je
5 Apr 23
Registration of securities issued in business combination transactions
4:40pm
S-4
EX-2.2
8pyt0en
5 Apr 23
Registration of securities issued in business combination transactions
4:40pm
8-K
EX-10.1
iba5cykn 1njl6
4 May 22
Adaptimmune Announces Appointment of Joanna Brewer as Chief Scientific Officer
8:20am
424B5
i3sueauq6tobljzv5a93
28 Apr 22
Prospectus supplement for primary offering
8:09am